- Home
- RVMD vs ASND Comparison
RVMD vs ASND Comparison
Compare RVMD & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVMD
- ASND
- Stock Information
- Founded
- RVMD 2014
- ASND 2006
- Country
- RVMD United States
- ASND Denmark
- Employees
- RVMD N/A
- ASND N/A
- Industry
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- RVMD Health Care
- ASND Health Care
- Exchange
- RVMD Nasdaq
- ASND Nasdaq
- Market Cap
- RVMD 8.7B
- ASND 7.7B
- IPO Year
- RVMD 2020
- ASND 2015
- Fundamental
- Price
- RVMD $44.39
- ASND $138.79
- Analyst Decision
- RVMD Strong Buy
- ASND Strong Buy
- Analyst Count
- RVMD 12
- ASND 13
- Target Price
- RVMD $64.67
- ASND $191.77
- AVG Volume (30 Days)
- RVMD 2.1M
- ASND 412.9K
- Earning Date
- RVMD 11-06-2024
- ASND 02-05-2025
- Dividend Yield
- RVMD N/A
- ASND N/A
- EPS Growth
- RVMD N/A
- ASND N/A
- EPS
- RVMD N/A
- ASND N/A
- Revenue
- RVMD $742,000.00
- ASND $365,187,374.00
- Revenue This Year
- RVMD N/A
- ASND $9.64
- Revenue Next Year
- RVMD $1,855.42
- ASND $79.86
- P/E Ratio
- RVMD N/A
- ASND N/A
- Revenue Growth
- RVMD N/A
- ASND 115.54
- 52 Week Low
- RVMD $25.93
- ASND $111.09
- 52 Week High
- RVMD $62.40
- ASND $161.00
- Technical
- Relative Strength Index (RSI)
- RVMD 34.18
- ASND 58.15
- Support Level
- RVMD $42.53
- ASND $134.53
- Resistance Level
- RVMD $44.22
- ASND $141.37
- Average True Range (ATR)
- RVMD 1.59
- ASND 5.21
- MACD
- RVMD -0.27
- ASND 0.57
- Stochastic Oscillator
- RVMD 28.46
- ASND 81.75
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates in North America, China, and Europe and derives the majority of its revenue from North America.